The information below has been supplied by dairy marketers and other industry organizations. It has not been edited, verified or endorsed by Hoard’s Dairyman
Administering intranasal vaccines is considered one of the most effective strategies to put protective immunity in place quickly and establish a strong foundation for future respiratory protection. These vaccines don’t just differ from injectable vaccines in route of administration. The nasal route of administration actually spurs a different immune response in cattle. This makes intranasal vaccines a key tool for producers battling respiratory illness in cattle, which has remained one of the top challenges to cattle health for decades.
Join Christopher Schneider, DVM, MS, Technical Services with Merck Animal Health, as he discusses the rationale and success behind intranasal vaccination in cattle. He will present important licensing data around response in calves to IBR, BRSV and PI3 antigens in Merck Animal Health’s new intranasal vaccine, Nasalgen 3®.
The American Association of Veterinary State Boards granted one Registry of Approved Continuing Education (RACE) credit for this DCHA webinar. Thus, veterinarians may earn one CE if they attend.